PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Nov-2023 Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2023 Sosei Heptares
10-Nov-2023 Veeva Pulse Shows Doctors Opening Up Two-Way Communications Doubles Digital Engagement Veeva Systems
10-Nov-2023 Formycon hosts conference call on nine-month figures 2023 and presents at further investor conferences Formycon AG
09-Nov-2023 Invitation to MorphoSys’ Third Quarter and First Nine Months 2023 Financial Results Conference Call on November 16, 2023 MorphoSys AG
09-Nov-2023 Gilead Sciences launches awards to celebrate and amplify the impactful work of community-based organizations across Australia, Canada and Europe Gilead Sciences
09-Nov-2023 PHARMANOVIA CEO, JAMES BURT APPOINTED CHAIR OF MEDICINES FOR EUROPE’S VALUE ADDED MEDICINES (VAM) SECTOR GROUP Pharmanovia
09-Nov-2023 NICE recommends Lamzede®▼ (velmanase alfa) as first ever enzyme replacement therapy for initiation in children with alpha-mannosidosis in England and Wales in final evaluation document Chiesi
09-Nov-2023 PM Society announces new Chair for 2024 PM Society
09-Nov-2023 Vetter’s European Clinical Site Receives Permanent Manufacturer’s Authorization B3C newswire
09-Nov-2023 Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test Mainz BioMed N.V.
09-Nov-2023 RHÖN-KLINIKUM AG increases consolidated profit and revenues RHÖN-KLINIKUM Aktiengesellschaft
09-Nov-2023 APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures for 2023 and new sales and earnings forecast for 2023 published APONTIS PHARMA AG
08-Nov-2023 APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program APONTIS PHARMA AG
08-Nov-2023 Gerresheimer AG: Groundbreaking ceremony for plant expansion in Querétaro, Mexico Gerresheimer AG
08-Nov-2023 Modus Therapeutics publishes interim report for the third quarter 2023 Modus Therapeutics
08-Nov-2023 Moberg Pharma´s Interim report January - September 2023 Moberg Pharma
08-Nov-2023 Collaboration agreement with new CT technology partner Kromek Group plc
08-Nov-2023 Shareholders of Abcam Approve Proposed Acquisition by Danaher Abcam plc
08-Nov-2023 Moberg Pharma strengthens the organization Moberg Pharma
08-Nov-2023 Continued strong performance in the third quarter of 2023 SYNLAB AG